The Richard C. Webster Resident Paper Contest: Our Second Year I n this issue, the Journal is pleased to present the 3 papers judged in this year's Richard C. Webster Contest. All were submitted by Fellows in American Academy of Cosmetic Surgery-approved Fellowship Training Programs. This is the second year of the Webster Contest, and as Editor-in-Chief, I can say that it is a pleasure to study these papers written by young investigators who have applied the scientific method to problems and questions in cosmetic surgery.
The winning paper, submitted by Cindy Y. Li, DO, and her fellowship director, Sorin Eremia, MD, of Riverside, California, is titled "Treatment of Leg and Face Veins With a Cryogen Spray Variable Pulse Width 1064 nm Nd:YAG Laser-A Prospective Study of 47 Patients." The authors show that the laser produces results similar to injection sclerotherapy when treating cutaneous spider veins and small subcutaneous reticular veins of the legs. More importantly, the laser is effective in the treatment of facial telangiectasia and periorbital reticular veins. Most of us have been reluctant to inject periorbital reticular veins, and heretofore one of the better treatments for these veins has been microstripping. We have had the same laser system in our clinic for nearly a year and have found it to be effective at energy fluences of 120 J/cm2 on leg veins and 80-100 J/cm2 on most facial telangiectasias. When treating larger vessels there is a moderate to severe hot cramping pain produced, which can be a limiting factor for some patients. If necessary, tumescent local anesthesia can be administered. Another consideration when using this laser is the longer treatment time compared to injection sclerotherapy. Overall, in appropriately selected patients, this laser system is a valuable addition to the surgeon's armamentarium.
The second paper, submitted from the University of Pittsburgh Medical Center by Suzan Obagi, MD, and her fellowship director, James B. Bridenstine, MD, is titled "Isotretinoin Use During Chemical Resurfacing: A Review of Complications." Suzan reviewed the patient records of her father, Zein E. Obagi, MD, who has a large practice of skin resurfacing with trichloroacetic acid. The study results are valuable to all surgeons who perform skin resurfacing because most of us have been reluctant to resurface patients who have taken isotretinoin from 6 months to 2 years prior to the procedure for fear of hypertrophic scarring. Anecdotal reports at meetings and case reports in the medical literature alluded to the increased risk of hypertrophic scarring for patients who have taken isotretinoin before the procedure. However, analysis of this large series of patients shows that taking isotretinoin several months or longer before resurfacing does not increase the already inherent risk of hypertrophic scarring. Because isotretinoin delays healing if it is taken in the perioperative period, and has negative effects if taken during the first few months postoperatively, it is advisable to avoid usage several months preoperatively and postoperatively. Does this study of trichloroacetic acid peeling translate to other forms of skin resurfacing? We suspect that it does. We have not seen a case of unexpected hypertrophic scarring with carbon dioxide or erbium: YAG laser resurfacing, or with dermabrasion with or without cryogen freezing of the skin. We teach that hypertrophic scarring does not develop unless the wound extends into the reticular dermis. It is not so important what is used to create the wound. It is the depth that counts. The deeper the wound into the reticular dermis, the more likely it is that hypertrophic scarring will develop. Our findings suggest that iso-tretinoin has a much narrower window of opportunity to negatively influence wound healing and scarring than previously thought.
The third paper this year, submitted by Jacob Haiavy, MD, DDS, and his fellowship director, Howard A. Tobin, MD, of Abiline, Texas, is titled "Augmentation Mammaplasty with Saline-filled Textured Implants: Review of 9 Years' Experience and Results of Patient Survey." The study comes from a practice with long and extensive experience in breast augmentation and reviews the authors' exclusive use of saline implants
The American Journal of Cosmetic Surgery Vol. 19, No.1, 2002 since 1992. Patients were satisfied with their results at a rate of 96.6%. Neither implant volume nor anatomical placeI?ent had a. sig~ificant influ.ence on pain, nipple sensation, or wrinkling. Interestingly, the patients reported a higher than expected rate of wrinkling and alteration of nipple sensation at 44.4% and 40.6% respectively.
We congratulate the authors for their fine work and thank them for their contributions to the Journal and the specialty of Cosmetic Surgery. We look forward to next year's Webster Contest papers.
